Small intestinal bacterial overgrowth: A comprehensive review

Gastroenterology and Hepatology

Volumn 3, Issue 2, 2007, Pages 112-122

  Dukowicz, Andrew C ^a   Lacy, Brian E ^a,b   Levine, Gary M ^a,b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Antibiotics; Bacterial overgrowth; Bloating; Diarrhea; Motility disorders; Small intestinal bacterial overgrowth

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CHLORTETRACYCLINE; CIMETIDINE; CIPROFLOXACIN; CISAPRIDE; DOXYCYCLINE; METRONIDAZOLE; NEOMYCIN; NORFLOXACIN; OCTREOTIDE; OMEPRAZOLE; PLACEBO; PROBIOTIC AGENT; PROKINETIC AGENT; RIFAXIMIN; TETRACYCLINE;

BACTERIAL OVERGROWTH; CHRONIC DIARRHEA; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC TEST; DISEASE ASSOCIATION; HIGH RISK PATIENT; HUMAN; IRRITABLE COLON; MALABSORPTION; PATHOGENESIS; PREVALENCE; REVIEW; SIDE EFFECT; SMALL INTESTINE DISEASE; STOMACH ACID; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

EID: 34248191158     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Fine D, Schiller LR. American Gastroenterological Association Medical Position Statement. Guidelines for the evaluation and management of chronic diarrhea. Gastroenterology. 1999;116:1464-1486.
2. Corrazza GR, Menozzi MG, Strocchi A, et al. The diagnosis of small bowel bacterial overgrowth: reliability of jejunal culture and inadequacy of breath hydrogen testing. Gastroenterology. 1990;98:302-309.
3. Issacs PE, Kim YS. Blind loop syndrome and small bowel bacterial contamination. Clin Gastroenterol. 1983;12:395-414.
4. Bouhnik Y, Alain S, Attar A, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol. 1999;94:1327-1331.
5. Parlesak A, Klein B, Schecher K, et al. Prevalence of small bowel bacterial overgrowth and its association with nutrition intake in nonhospitalized older adults. J Am Geriatr Soc. 2003;51:768-773.
6. Mitsui T, Kagami H, Kinomoto H, et al. Small bowel bacterial overgrowth and rice malabsorption in healthy and physically disabled older adults. J Hum Nutr Dietet. 2003;16:119-122.
7. Teo M, Chung S, Chitti L, et al. Small bowel bacterial overgrowth is a common cause of chronic diarrhea. J Gastro Hepatol. 2004;19:904-909.
8. Lewis SJ, Potts LF, Malhotra R, et al. Small bowel bacterial overgrowth in subjects living in residential care homes. Age Ageing. 1999;28:181-185.
9. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003;98:412-419.
10. Riordan SM, McIver CJ, Wakefield D, et al. Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora. Am J Gastroenterol. 2001;96:494-500.
11. Haboubi NY, Lee GS, Montgomery RD. Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: Response to antibiotics treatment. Age Ageing. 1991;20:29-32.
12. Saltzman JR, Kowdley KV, Pedrosa MC, et al. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric subjects. Gastroenterology. 1994;106:615-623.
13. Husebye E, Skar V, Hoverstad T, et al. Fasting hypochlorhydria with gram positive gastric flora is highly prevalent in healthy old people. Gut. 1992;33:1331-1337.
14. Iivonen MK, Ahola TO, Matikainen MJ. Bacterial overgrowth, intestinal transit, and nutrition after total gastrectomy. Scan J Gastroenterol. 1998;33:63-70.
15. Brandi G, Biavati B, Calabrese C, et al. Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosa. Am J Gastroenterol. 2006;101:1756-1761.
16. Shindo K, Fukumura M. Effect of H2-receptor antagonists on bile acid metabolism. J Investig Med. 1995;43:170-177.
17. Thorens J, Froehlich F, Schwizer W, et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut. 1996;39:54-59.
18. Lewis SJ, Franco S, Young G, et al. Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole. Aliment Pharmacol Ther. 1996;10:557-561.
19. Vantrappen G, Janssens J, Hellemans J, et al. The interdigestive motor complex of normal subjects and patients with bacterial overgrowth of the small intestine. J Clin Invest. 1977;59:1158-1166.
20. Stotzer PO, Bjornsson ES, Abrahamsson H. Interdigestive and postprandial motility in small-intestinal bacterial overgrowth. Scan J Gastroenterol. 1996;31:875-880.
21. Husebye E, Skar V, Hoverstad T, et al. Abnormal intestinal motor patterns explain enteric colonization with gram-negative bacilli in late radiation enteropathy. Gastroenterology. 1995;109:1078-1089.
22. Lacy BE, Koch KL, Crowell MD. Manometry. In: Schuster MM, Crowell MD, Koch KL, eds. Atlas of Gastrointestinal Motility. 2nd ed. Hamilton, B.C. Decker. 2002:135-150.
23. Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1592-1622.
24. Nieuwenhuijs VB, Verheem A, Van Duijvenbode-Beumer H, et al. The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats. Ann Surg. 1998; 228:188-193.
25. Gunnarsdotrir SA, Sadik R, Shev S, et al. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol. 2003;98:1362-1370.
26. Strid H, Simren M, Stotzer PO, et al. Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth. Digestion. 2003;67:129-137.
27. Wegener M, Adamek RJ, Wedmann B, et al. Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci. 1994;39:2209-2215.
28. Kaye SA, Lim SG, Taylor M, et al. Small bowel bacterial overgrowth in systemic sclerosis: detection using direct and indirect methods and treatment outcome. Brit J Rheumatol. 1995;34:265-269.
29. Armbrecht U, Lundell L, Lindstedt G, et al. Causes of malabsorption after total gastrectomy with Roux-en-Y reconstruction. Acta Chir Scand. 1988;154:37-41.
30. Akhrass R, Yaffe MB, Fischer C, et al. Small-bowel diverriculosis: perceptions and reality. J Am Coll Surg. 1997;184:383-388.
31. Swan RW. Stagnant loop syndrome resulting from small-bowel irradiation injury and intestinal by-pass. Gynecol Oncol. 1974;8:441-445.
32. Castiglione F, Del Vecchio Blanco G, Rispo A, et al. Orocecal transit time and bacterial overgrowth in patients with Crohn's disease. J Clin Gastroenterol. 2000;31:63-66.
33. Pignata C, Budillon G, Monaco G, et al. Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut. 1990;31:879-882.
34. Riordan SM, McIver CJ, Wakefield D, et al. Serum immunoglobulin and soluble IL-2 receptor levels in small intestinal overgrowth with indigenous gut flora. Dig Dis Sci. 1999;44:939-944.
35. Riordan SM, McIver CJ, Wakefield D, et al. Small intestinal bacterial overgrowth in the symptomatic elderly. Am J Gastroenterol. 1997;92:47-51.
36. McLoughlin GA, Hede JE, Temple JG, et al. The role of IgA in the prevention of bacterial colonization of the jejunum in the vagotomized subject. Br J Surg. 1978;65:435-437.
37. Wilcox CM, Waites KB, Smith PD. No relationship between gastric pH, small bowel bacterial colonization, and diarrhoea in HIV-1 infected patients. Gut. 1999;44:101-105.
38. Lacy BE, DeLee R. Irritable Bowel Syndrome: A syndrome in evolution. J Clin Gastroenterol. 2005;39:S230-S242.
39. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms in irritable bowel syndrome. Am J Gastroenterol. 2000;95:3503-3506.
40. Nucera G, Gabrielli M, Lupascu A, et al. Abnormal breath tests to lactose, fructose, and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2005;21:1391-1395.
41. Parisi G, Leandro G, Bottona E, et al. Small intestinal bacterial overgrowth and irritable bowel syndrome [letter]. Am J Gastroenterol. 2003;98:2572.
42. Walters B, Vanner SJ. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: Comparison with the 14C-d-xylose and healthy controls. Am J Gastroenterol. 2005;1566-1570.
43. Pimentel M, Soffer EE, Chow EJ, et al. Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth. Dig Dis Sci. 2002;47:2639-2643.
44. Virally-Monod M, Tielmans D, Kevorkian JP, et al. Chronic diarrhea and diabetes mellitus: prevalence of small intestinal bacterial overgrowth. Diabetes Metab. 1998;24:530-536.
45. Urita Y, Ishihara S, Akimoto T, et al. Seventy-five gram glucose tolerance test to assess carbohydrate malabsorption and small bowel bacterial overgrowth. World J Gastroenterol. 2006;12:3092-3095.
46. Husebye E, Engedal K. The patterns of motility are maintained in the human small intestine throughout the process of aging. Scand J Gastroenterol. 1992;27:397-404.
47. Melkersson M, Andersson H, Bosaeus I, et al. Intestinal transit time in constipated and non-constipated geriatric parients. Scand J Gastroenterol. 1983;18:593-597.
48. Tursi A. Gastrointestinal motility disturbances in celiac disease. J Clin Gastroenterol. 2004;38:642-645.
49. Tursi A, Brandimarte G, Giorgetti GM. High prevalence of small intestinal bacterial overgrowth in celiac patients with persistence of gastrointestinal symptoms after gluten withdrawal. Am J Gastroenterol. 2003;98:839-843.
50. Deitch EA, Sittig K, Li M, et al. Obstructive jaundice promotes bacterial translocation from the gut. Am J Surg. 1990;159:79-84.
51. Madrid AM, Cumsille F, Defillippi C. Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig Dis Sci. 1997;42:738-742.
52. Chang CS, Chen GH, Lien HC, et al. Small intestine dysmorility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology. 1998;28:1187-1190.
53. Morencos FC, de las Heras Castano G, Martin Ramos L, et al. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci. 1995;40:1252-1256.
54. Bauer TM, Steinbruckner B, Brinkmann FE, et al. Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol. 2001;96:2962-2967.
55. Bauer TM, Schwacha H, Steinbruckner B, et al. Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol. 2002;97:2364-2370.
56. Chang CS, Yang SS, Kao CH, et al. Small intestinal bacterial overgrowth versus antimicrobial capacity in patients with spontaneous bacterial peritonitis. Scand J Gastroenterol. 2001;36:92-96.
57. Li YF, Newton TJ, Weisbrodt NW, et al. Intestinal migrating myoelectrical complexes in rats with acute pancreatitis and bile duct ligation. J Surg Res. 1993;55:182-187.
58. Van Felius ID, Akkermans LMA, Bosscha K, et al. Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil. 2003;15:267-276.
59. Trespi E, Ferrieri A. Intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin. 1999;15:47-52.
60. Hauge T, Persson J, Danielsson D. Mucosal bacterial growth in the upper gastrointestinal tract in alcoholics (heavy drinkers). Digestion. 1997;58:591-595.
61. Stotzer PO, Johansson C, Mellstrom D, et al. Bone mineral density in patients with small intestinal bacterial overgrowth. Hepatogastroenterology. 2003;50:1415-1418.
62. Saltzman JR, Russell RM. Nutritional consequences of intestinal bacterial overgrowth. Comp Ther. 1994;20:523-530.
63. Shindo K, Machinda M, Koide K, et al. Deconjugation ability of bacteria isolated from the jejunal fluid of patients with progressive systemic sclerosis and its gastric pH. Hepatogastroenterology. 1998;45:1643-1650.
64. Wanitschke R, Ammon HV. Effects of dihydroxy bile acids and hydroxyl fatry acids on the absorption of oleic acid in the human jejunum. J Clin Invest. 1978;61:178-186.
65. Gianella RA, Rout WR, Toskes PP. Jejunal brush border injury and impaired sugar and amino acid uptake in the blind loop syndrome. Gastroenterology. 1974;67:965-974.
66. King CE, Toskes PP. Protein-losing enteropathy in the human and experimental rat blind-loop syndrome. Gastroenterology. 1981;80:504-509.
67. Welkos SL, Toskes PP, Baer H. Importance of anaerobic bacteria in the cobalamin malabsorption of the experimental rat blind loop syndrome. Gastroenterology. 1981;80:313-320.
68. Suter PM, Golner BB, Goldin BR, et al. Reversal of protein-bound vitamin B12 malabsorption with antibiotics in atrophic gastritis. Gastroenterology. 1991;101:1039-1045.
69. Russell RM, Krasinski SD, Samloff IM, et al. Folic acid malabsorption in atrophic gastritis: Possible compensation by bacterial folate synthesis. Gastroenterology. 1986; 91: 1476-1482.
70. Camilo E, Zimmerman J, Mason JB, et al. Folate synthesized by bacteria in the human upper small intestine is assimilated by the host. Gastroenterology. 1996;110:991-998.
71. Romagnuolo, J, Schiller, D, Bailey, RJ. Using breath tests wisely in a gastroenterology practice: an evidence-based review of indications and pitfalls in interpretation. Am J Gastroenterol. 2002; 97:1113-1126.
72. Riordan SM, McIver CJ, Duncombe VM, et al. Evaluation of the rice breath hydrogen test for small intestinal bacterial overgrowth. Am J Gastroenterol. 2000;95:2858-2864.
73. King CE, Toskes PP, Guilarte TR, et al. Comparison of the one-gram d-[14C]xylose breath test to the [14C]bile acid breath test in patients with small-intestine bacterial overgrowth. Dig Dis Sci. 1980;25:53-58.
74. Swart GR, van den Berg JW. 13C breath tests in gastroenterological practice. Scand J Gastroenterol Suppl. 1998;225:13-18.
75. King CE, Toskes PP. Comparison of the 1 gram 14C-D-xylose, 10 gram lactulose and 80 gram glucose H2 breath test in patients with small intestinal bacterial overgrowth. Gastroenterology. 1986;91:1447-1451.
76. Fromm H, Hofmann AF. Breath test for altered bile-acid metabolism. Lancet. 1971; 2: 621-625.
77. 75Se-labelled homocholic-tauro acid, and scanning electron microscopy. Scan J Gastroenterol. 1990;25:841-852.
78. Gibson GR, Cummings JH, Macfarlane GT, et al. Alternative pathways for hydrogen disposal during fermentation in the human colon. Gut. 1990;31:679-683.
79. Bjorneklett A, Fausa O, Midvedt T. Small-bowel bacterial overgrowth in the postgastrectomy syndrome. Scan J Gastroenterol. 1983;18:277-287.
80. Salzberg DM, Levine GM, Lubar C. Impact of age, sex, race, and functional complaints on hydrogen (H2) production. Dig Dis Sci. 1988;33:308-314.
81. Hutchinson S, Logan R. The effect of long-term omeprazole on the glucose-hydrogen breath test in elderly patients. Age Ageing. 1997;26:87-89.
82. Kerlin P, Wong L. Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology. 1988;95:982-988.
83. 14C-D-xylose and healthy controls. Am J Gastroenterol. 2005;100:1566-1570.
84. 14C-D-xylose breath test and jejunal cultures in 60 patients. Scand J Gastroenterol. 1985;20:1267-1275.
85. 14C-D-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion. 2000;61:165-171.
86. Goshal UC, Goshal U, Das K, et al. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome, and its relationship with oro-cecal transit time. Indian J Gastroenterol. 2006;25:6-10.
87. Riordan SM, McIver CJ, Walker BM, et al. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 1996;91:1795-1803.
88. Chang CS, Chen GH, Kao CH, et al. Increased accuracy of the carbon-14 D-xylose breath test in detecting small-intestinal bacterial overgrowth by correction with the gastric emptying rate. Eur J Nucl Med. 1995;22:1118-1122.
89. Perman JA, Modler S, Barr RG, et al. Fasting breath hydrogen concentration: normal values and clinical application. Gastroenterology. 1984;87:1358-1363.
90. Madrid AM, Hurtado C, Venegas M, et al. Long-term treatment with cis-apride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Am J Gastroenterol. 2001;96:1251-1255.
91. Edmunds MC, Chen JD, Soykan I, et al. Effect of octreotide on gastric and small bowel motility in patients with gastroparesis. Aliment Pharmacol Ther. 1998;12:167-174.
92. Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991;325:1461-1467.
93. Bishop WP. Breath hydrogen testing for small bowel bacterial overgrowth - a lot of hot air? J Pediatr Gastroenterol Nutr. 1997;25:245-246.
94. Di Stefano M, Miceli E, Missanelli A, et al. Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment Pharmacol Ther. 2005;21:985-992.
95. Di Stefano M, Malservisi S, Veneto G, et al. Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2000;14:551-556.
96. Castiglione F, Rispo A, Di Girolamo E, et al. Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther. 2003;18:1107-1112.
97. Attar A, Flourie B, Rambaud JC, et al. Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology. 1999;117:794-797.
98. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome, a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003;92:412-419.
99. Pimentel M, Park S, Mirocha J, et al. The effect of a nonabsorbed oral antibiotic (Rifaxamin) on the symptoms of the irritable bowel syndrome. Ann Intern Med. 2006;145:557-563.
100. Gaon D, Garmendia C, Murrielo NO, et al. Effect of Lactobacillus strains (L. casei and L. Acidophilus Strains cerela) on bacterial overgrowth-related chronic diarrhea. Medicina. 2002;62:159-163.
101. Stotzer PO, Blomberg L, Conway PL, et al. Probiotic treatment of small intestinal bacterial overgrowth by Lactobacillus fermentum KLD. Scand J Infect Dis. 1996;28:615-619.